Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT01862978
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01862978
-
- Other papers using this trial's data
- The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Slovakia
- Registry status
- Unknown status
Technical summary
Registry record NCT01862978. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
- Acronym
- Heparinas
- Condition
- Acute Ischemic Stroke
- Intervention (Drug)
- Heparin
- Intervention (Drug)
- Nadroparin
- Intervention (Drug)
- Placebo
- Lead sponsor
- University Hospital, Martin
Record details
- Record id
cardio:ct-nct01862978- Content hash
5671fdaaf80f12a7a0c30eeba16ef9167c7e87a091615e9fc53acfcbf1db7607